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ABSTRACT Surface immunoglobulin (1g)-mediated endocytosis has been investigated in rat B
lymphocytes and plasma cells, using horseradish peroxidase (HRP)-labeled sheep anti-rat Ig
Fab' fragment of antibody and HRP as monomeric ligands, respectively. Quantitative estimates
of HRP activity associated either with plasma membrane or with endomembrane compart-
ments were made in several experimental conditions. Binding of HRP-conjugate on B lympho-
cytes was followed by its endocytosis in combination with surface Ig, as shown by the
progressive disappearance of plasma membrane-associated HRP activity. Between 1 and 6 h
at 37°C in presence of conjugate the total amount of cell-associated activity was constant.
These results indicate that during this time no reappearance of surface Ig occurred by
neosynthesis, by the expression of an intracellular pool or by the recycling in a free form of
the previously internalized molecules . On the contrary, at saturating doses, internalization of
HRP by anti-HRP plasma cells increased linearly with time at 37°C in presence of antigen,
when, during the same time, the plasma membrane HRP-binding capacity remained constant.
Cycloheximide. did not affect continuous HRP uptake. The existence of a large intracellular
pool of receptors has been ruled out by experiments of removal of binding sites with pronase .
In addition, monensin caused a progressive decrease in the number of surface receptors on
plasma cells but not on B lymphocytes . Our data then indicate that, unlike B lymphocytes,
plasma cells were able to recycle their surface Ig.
Receptor-mediated endocytosis ofligands has been described
in various cell types (reviewed in references 18 and 36),
including B lymphocytes (3, 27, 35, 45) and plasma cells (3,
20). In some cells and/or with some ligand-receptor systems,
a temporary loss of membrane receptors is observed after
internalization of the ligand-receptor complexes. The so-
called down regulation, process has been principally docu-
mented for receptors whose major role is to convey a signal
to a target cell, such as receptors for polypeptide hormones
or neurotransmitters (reviewed in references 11 and 26). The
most widely accepted explanation ofthis phenomenon is that,
after internalization, ligand-receptor complexes are trapped
within the lysosomes and degraded. Reexpression of new
receptors appears to require de novo synthesis. In other cell
types and/or with other ligand-receptor systems, a distinct
behavior of the receptors has been described. After internali-
zation of the complexes, receptors are not catabolized, but
return to the plasma membrane, either complexed with the
ligand (43) or in a free form (18, 25, 37, 43). This process was
termed receptor recycling and allows for an efficient delivery
of ligands to intracellular sites (mainly the lysosomes), either
to provide nutritional molecules inside the cells or to degrade
injurious agents.
How some receptors escape from intracellular degradation
whereas others are degraded remains poorly understood. The
aim of this study was to determine whether the cellular
differentiation state can affect receptor behavior. We have
addressed this question with immunocytes of the B lineage.
Immunocompetent resting B lymphocytes express surface
immunoglobulins (Ig) on their plasma membrane, through
which they recognize antigens. Up to now, surface Ig-medi-
ated endocytosis has been principally studied by means of
ligands (antigen or anti-Ig antibodies) that induce redistribu-
tion (patching and capping) of surface Ig (27, 35, 45). Inter-
nalization of ligand-surface Ig complexes leaves the cell free
of surface Ig and their reexpression requires protein synthesis
(45). However, it has been recently reported that divalent
antibodies directed against low density lipoprotein receptor
of fibroblasts inhibit the recycling of receptor, whereas Fab
fragments do not (2). It was then of interest to further inves-
tigate endocytosis of a monomeric ligand in B lymphocytes.
We present here a study on the internalization of Fab' frag-
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Binding of antigen or anti-Ig antibodies on the surface Ig
delivers a signal that, in combination with other signals,
activates B lymphocytes. Once activated, B lymphocytes pro-
liferate and differentiate in plasma cells. In these latter cells,
the majority of Ig molecules, instead of participating in the
membrane recognition mechanisms are now secreted in large
amounts. However, throughout the process of differentiation,
B cells continue to express surface Ig, although their number
progressively decreases (31) and plasma cells still exhibit
detectable numbers of surface receptors for antigen (23, 29).
In the present study, we have investigated receptor-mediated
endocytosis of antigen in plasma cells using horseradish per-
oxidase (HRP)' as monomeric antigen and popliteal lymph
node cells of HRP-immunized rats as source ofplasma cells.
We present evidence of a very different kinetics of mono-
meric ligand uptake in B lymphocytes and plasma cells. Our
data suggest that the differences observed can be explained by
a surface Ig recycling in plasma cells, but not in B lympho-
cytes.
MATERIALS AND METHODS
Sources of Materials:
￿
HRP was obtained from Boehringer (Grade I,
Mannheim, Federal Republic of Germany [FRG]) and Incomplete Freund's
adjuvant from Difco Laboratories (Detroit, MI). Cycloheximide, monensin,
and rabbit y-globulins (B grade) were purchased from Calbiochem (La Jolla,
CA), Pronase E (70,000 PUK/g), 30% H202 and 2-mercaptoethanol from
Merck-Schuhardt(Darmstadt, FRG), DNase II(880.5 U/mg) and pepsin (2900
U/mg) from Worthington Biochemicals (Freehold, NJ). Nonidet P-40 (NP-40),
O-dianisidine DiHCl (OD), O-phenylenediamine DiHCI (OPD), and 3-amino-
9-ethyl carbazole were obtained from Sigma Chemical Co. (St. Louis, MO),
iodoacetamide from Aldrich Chemical Co. (Milwaukee, WI), Ultrogel AcA 44,
and DEAE-trisacryl M from IBF (Villeneuve-La-Garenne, France)and Sephac-
ryl 5-200 from Pharmacia Fine Chemicals (Uppsala, Sweden). 1,4-benzoqui-
none was purchased from Fluka AG (Buchs, Switzerland) and r.-['H]leucine
(50 Ci/mmol) from Commissariat i l'Energie Atomique (Saclay, France).
Animals:
￿
Malerats oftheFischer344 strainwereused. Theywerereared
in specific pathogen-free conditions in the breeding center of the Pasteur
Institute (Dr. J. L. Gu6net).
Antigens and Immunizations:
￿
5-6-mo-old rats were immunized
by subcutaneous injections, in each hind footpad, of 0.5 mg of HRP or rabbit
y-globuns emulsified in IFA. 2 mo to 1 yr later, secondary immunizations
were carried out in the same way with 0.25 mg of HRP or rabbit y-globulins
in each hind footpad. Rats were killed 4 d later using a lethal dose ofether.
Preparation of HRP-conjugates:
￿
immunization ofsheep with rat
IgG and isolation of specific antibodies by affinity chromatography on immu-
noadsorbents were described elsewhere (5, 41). Sheep anti-rat Ig antibodies
were pepsin-digested according to Nisonoffet al. (30), reduced with 2-mercap-
toethanol and alkylated with iodoacetamide. Sheep anti-rat Ig Fab' were
purifiedby filtrationthrough a Sephacryl 5-200columncalibrated for molecular
weight determinations. Fab' fragments ofnormal sheep IgG were prepared as
followed. Normal sheep serum was chromatographed on DEAE-trisacryl M
equilibrated with 0.025 M Tris, HCI buffer, pH 8.8, 0.035 M NaCl. The IgG
eluted at this ionic strength were concentrated by precipitation with 40%
ammonium sulphate, pepsin-digested as above and the Fab' fragments were
purified by filtration on Sephacryl S-200.
Sheep anti-rat Ig Fab' and normal sheep Fab' were covalently linked to
HRP by a two-step procedure (6). The labeled Fab' preparations were passed
through a Sephacryl 5-200 column and fractions corresponding to a molecular
weight of 80,000 containing Fab'-HRP conjugate in a 1:1 molar ratio were
pooled and used in the present experiments.
In some experiments, HRP-labeled normal sheep (Fab')2 and sheep anti-rat
Ig (Fab')2 conjugates were used. (Fab')2 fragments were prepared by pepsin
digestion and covalently linked with HRP (6). After coupling, these conjugates
wereusedwithout anyfurther purification orafterfiltrationthrough a Sephacryl
'Abbreviations used in this paper: HRP, horseradish peroxidase;
NP-40, Nonidet P-40; OD, O-dianisidine DiHCI; OPD, O-phenyl-
enediamine DiHCI; SRBC, sheep erythrocyte.
S-200 column as described above. In this latter case, fractions containing
(Fab')2-HRP conjugate free of unlabeled (Fab')2 fragments were selected. The
HRP/(Fab')2 molar ratios ofthe selected conjugates were 1 .8-1.9.
Preparation of Cells:
￿
Normal lymphoid cells were prepared from
cervical and mesenteric lymph nodes of 9-10-mo-old rats. After bleeding by
cardiac puncture, organswere removed and teased in Hanks' medium (Institut
Pasteur Production, Paris, France) containing 10% Haemaccel (Laboratoires
Hoechst, Puteaux, France). To deplete macrophages, we passed lymphoid
populations through AcA 44 acrylamide-agarose beads as previously described
(21). Recovered cells were resuspended in modified Click's medium (12)
buffered with 20 mM HEPES (Flow Laboratories, Irvine, UK) supplemented
with 3 x 10-' M 2-mercaptoethanol and 10% fetal calf serum.
Anti-HRP and anti-rabbit y-globulin lymphoid cells were prepared as de-
scribed above from popliteal lymph nodes of HRP-or rabbit y-globulin-im-
munized rats that had received a booster injection 4 d earlier. Cell viability, as
tested by trypan blue exclusion, was at least 90% in our experiments.
HRP Binding and Uptake Assays:
￿
The binding of HRP or HRP
conjugates to cells was measured by incubating them (5 x 10'/ml) for 1 h at
4°C with various concentrations ofHRP or HRP conjugates inmodifiedClick's
medium. After three washings, cell-bound HRP was estimated quantitatively
by measuring enzymatic activity. 0.1 ml of the cell suspension was added to
2.9 ml of isotonic buffer containing enzyme substrate. The binding of HRP
conjugates to B lymphocytes was studied using OD substrate prepared as
described earlier (4, 2l ). Thebinding ofHRP to plasma cellswas studied using
OPD (46). OPD and H202 were dissolved in 0.15 M phosphate buffer, pH 6.0
(0.5 mg OPD/ml and 0.015% H202). The reaction was allowed to proceed for
15 min in the dark at room temperature and was stopped by adding 300 kl of
6 N HCI. The suspension was then centrifuged at 350 g for 7 min and the
absorbance of the colored supernatant was read at 492 nm.
The uptake ofHRPor HRP conjugatesby cellswas measuredby incubating
them at 37°C with HRP or HRP conjugates for various periods of time in
modified Click's medium (5 x 106 cells/ml). After four washings, 0.05 ml of
the cell suspension was lysed with 0.05 ml of 1% NP-40 in solution in
phosphate-buffered saline (0.01 M potassium phosphate buffer pH 7.4; 0.15 M
NaCI). After incubation for 10 min at room temperature, HRP activity was
measured using OD or OPD as described above.
Quantities of cell-bound HRP were calculated by referring to a standard
curve ofHRP activity.
Pronase Treatment of Lymphoid Cells:
￿
To remove cell surface-
bound HRP or HRP conjugates, we incubated cells for 20 to 30 min at 37°C
in modifiedClick'smediumwithout fetal calfserum, and with 2 mg/mlpronase
(previously heated 45-60 min at 37°C) and 50 Ag/ml DNase II. After two
washings in Hanks' Haemaccel, cell-associated activity was measured. To
remove membrane receptors on plasma cells, we incubated cells for 15 min at
4°C with the same concentrations of pronase and DNase II. Cells were then
washed fourtimes in Hanks' medium containing 10% FCS before reincubation
at 37°C.
Cytochemical Detection of Cell-bound HRP:
￿
After incuba-
tion of normal or immune lymphoid cells with HRP conjugates or HRP,
respectively, cells were spread on a microscopic slide using a cytocentrifuge
(Shandon Southern Products, Inc., Sewickley, PA). Fixation of cellsand detec-
tion of HRP using 3amino-9-ethyl carbazole as chromogenic substrate were
previously described (21, 22). Percentages of stained cells were calculated after
counting 1,000-1,500 cells on each slide.
Detection of Antibody-secreting Cells:
￿
Anti-HRP antibody-
secreting cells were detected using the plaque-forming cell assay described by
Cunningham and Szenberg (13). In this assay, sheep erythrocytes (SRBC),
covalently linked to HRP with 1,4benzoquinone, were usedas targets (42) and
a polyspecific rabbit anti-rat Ig serum was used as enhancing serum. A guinea
pig serum previously adsorbed on SRBC was used as a source ofcomplement.
Biosynthetic Labeling:
￿
To determinethe effect ofcycloheximide on
protein synthesis, we incubated lymph node cells from anti-HRP rats for 1 h
at 37°C in modified Eagle's culture medium free of L-leucine (Flow Laborato-
ries) containing 60 wCi/ml of r.-['H]leucine. Trichloroacetic acid-precipitable
radioactivity was then counted.
RESULTS
Binding of HRP-labeled Anti-rat Ig Fab' Fragment
on B Lymphocytes
With B lymphocytes, the surface Ig-mediated endocytosis
process was studied using HRP-labeled sheep anti-rat Ig Fab'
fragment as monomeric ligand. The binding of this ligand
was measured by incubating macrophage-depleted normal
GOUD AND ANTOINE Surface Ig Recycling and B Lymphocyte Differentiation
￿
1239lymph node cells for 1 h at 4°C with various concentrations
of conjugate. The amount of cell-bound HRP was then esti-
mated as described in Materials and Methods. As shown in
Fig. 1, the binding was a specific saturable process. A plateau
was reached with 120 Aig/ml of conjugate. The nonspecific
binding, measured by incubating cells with HRP-labeled nor-
mal Fab' fragment, represented 3-11 % of the specific one. At
the light microscopic level the maximum number of surface
Ig-positive cells which varied between 36 and 46% ofthe cells,
was obtained with 50-100 ug/ml of conjugate. No positive
cells were observed with the control conjugate.
After incubation at 4°C with conjugate, the amount of cell-
bound HRP was also determined after lysis ofcells with NP-
40 and compared to the amount of HRP detected on intact
cells. Difference between the two values, termed NP-40 re-
leasable HRP, was found to be very small, as shown in Fig.
1 . In addition, the pronase treatment of living labeled cells
removed most of the activity previously titrated on intact
cells, without significantly affecting the lowamount ofNP-40
releasable activity (Table I, experiments 1 and 2). This indi-
cates that at 4°C, most of the HRP activity was associated to
the cell surface.
Internalization of HRP-labeled Anti-rat Ig Fab'
Fragment by B Lymphocytes
HRP conjugate uptake was studied by incubating normal
lymphoid cellsat 37°C with 200,ug/ml ofconjugate. As shown
in Table I (experiment 3), pronase removed most ofthe HRP
activity titrated on intact cells. Furthermore, the proteolytic
digestion did not significantly modify the amount of NP-40
releasable activity. We have then attributed the HRP activity
detected on intact cells to plasma membrane-bound HRP
conjugate molecules, and the NP-40 releasable activity to
internalized HRP conjugate molecules.
Normal lymphoid cells were incubated 1 h at 4°C or 1, 3,
and 6 h at 37°C with anti-rat Ig conjugate and the HRP
activity associated with different compartments of the cells
was estimated. With time of incubation at 37°C, we observed
HRP -CONJUGATE (Yq / ml )
FIGURE 1
￿
Binding of HRP-labeled sheep anti-rat Ig Fab' fragment
on B lymphocytes. Macrophage-depleted mesenteric and cervical
lymph node cells (5 x 10'/ml) were incubated 1 h at 4°C with
various concentrations of conjugate in modified Click's medium.
Titration of cell-associated HRP was performed with CID chromo-
genic substrate either on living cells (9) or after lysís of cells with
NP-40 (0). Nonspecific binding was measured by incubating cells
with HRP-labeled normal sheep Fab' . Titration of cell-associated
HRP was performed either on living cells (o) or on cell lysates (p).
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TABLE I
Binding and Internalization of HRP-labeled Sheep Anti-rat Ig
Fab' by B Lymphocytes
Normal lymphoid cells were incubated for 1 h at 4°C or 37°C with 200 kg/
ml HRP-labeled sheep anti-rat Ig Fab'. After washing, one portion of cells
was treated 20 to 30 min at 37°C with pronase. Then, HRP activity was
titrated on living cells (third and fourth columns). Amounts of NP-40 releas-
able HRP before and after treatment of cells with pronase are indicated in
the fifth and sixth columns.
a progressive clearance of plasma membrane-bound HRP
(Fig. 2). After 6 h at 37°C the surface-binding capacity of the
cells was -20% of the binding capacity at 4°C. This decrease
was due to an internalization of (surface Ig-HRP conjugate)
complexes because the amount of NP-40 releasable HRP
simultaneously increased to reach a plateau after 3 h of
incubation. In these conditions, the percentage of HRP-la-
beled cells was constant and similar to the percentage of
conjugate-binding cells counted at 4°C (Fig. 2). As for the
results obtained at 4°C, the nonspecific binding and internal-
ization measured by incubating cells with HRP-labeled nor-
mal sheep Fab' were very low (on the order of 5-10% ofthe
values found with the specific conjugate) regardless of the
incubation time at 37°C, and no positive cells could be
detected with this conjugate.
As shown in Fig. 2 both the binding and the internalization
process were unaffected by cycloheximide which at the dose
used inhibited protein synthesis by 93% . The most interesting
point was that from 1 to 6 h at 37°C the total amount of cell-
associated HRP was constant. This probably indicates that
once internalized under the form of immune complexes the
surface Ig do not come back at the cell surface in a free form
to be recycled. No adjustment for the degradation process of
HRP was needed in these conditions since we had previously
demonstrated that HRP can remain a long time (at least 6 h)
in intracellular sites of lymphocytes without any alteration of
its enzymatic activity, and even after this lag, the rate of
inactivation was low (50% in 18 h) (21). An observation more
difficult to interpret was the difference measured for the total
amount of cell-associated HRP activity between cells incu-
bated 1 h at 4°C and 1 h at 37°C (Fig. 2). The average ratio
between the values obtained at 37°C and those obtained at
4°C was 2.2. This might be due to a rapid neosynthesis of
surface Ig during the first hour ofincubation, or to the rapid
expression of an intracellular pool of surface Ig. The first
hypothesis was ruled out as cycloheximide-treated cells
showed the same increase between 1 h at 4°C and 1 h at 37°C
(Fig. 2). The second explanation was also unlikely because
after a 15-min exposure of lymphoid cells to pronase, which
removed 88% of the surface Ig, followed by a I h postincu-
bation at 37°C, no reexpression of surface Ig was observed.
Amount
of HRP
de- Amount of NP-40
tected releasable HRPI107
Amount on 10' cells
Tempera- of HRP living
ture of in- detected cells Before After
cubation on 10' treated pronase pronase
Experi- with con- living with treat- treat-
ment jugates cells pronase ment ment
.C ng ng ng
1 4 59.3 1 .6 11 .7 10.2
2 4 48.1 2.6 7.4 8.4
3 37 27.7 4.2 73 .1 66.7We then performed experiments with the bivalent conjugate
HRP-labeled sheep anti-rat Ig (Fab%. As shown in Table II,
the average ratio between the values obtained at 37°C and
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FIGURE 2
￿
Uptake of HRP-labeled sheep anti-rat Ig Fab' fragment
by B lymphocytes. Macrophage-depleted mesenteric and cervical
lymph node cells (5 x 10'/ml) were incubated at 4°C (time 0) or
37°C with 200 jug/ml conjugate in modified Click's medium and
with (-) or without (-----) 20 jug/ml cycloheximide. After 1 h at
4°C and 1, 3, and 6 h at 37°C, aliquots of cells were withdrawn
and cell-associated HRP activity estimated by using OD as chro-
mogenic substrate. (9) Nanograms of plasma membrane-bound
HRP/10' cells; (p) nanograms of internalized HRP/10' cells; (IM total
amount of cell-associated HRP in ng/10' cells. Results shown in this
figure are the means of two separate experiments. Corrections for
nonspecifically bound or internalized HRP conjugate are already
made in the presented data. Nonspecific binding and internalization
were estimated by incubating aliquots of the same cell suspensions
with HRP-labeled normal sheep Fab' . In parallel, aliquots of cells
were prepared for cytochemical detection of HRP-labeled cells.
After cytocentrifugation and fixation, cell preparations were dipped
in 3-amino-9-ethyl carbazole substrate. Results are expressed in
percent of lymphoid cells labeled with HRP-conjugate (O).
those obtained at 4°C was between 1 .04 and 1 .26 which
indicates that most, if not all, bivalent conjugate-binding sites
were accessible at 4°C on the cell surface. Taken together, the
above results suggest that a part of the surface Ig molecules
or determinants were probably not accessible at 4°C to the
monovalent conjugate.
Binding of HRP on Anti-HRP Plasma Cells
With plasma cells, the surface Ig-mediated endocytosis
process was studied using HRP as the monomeric ligand. The
cellsused for this study were popliteal lymph node cells taken
from anti-HRP rats, having received a booster injection 4 d
earlier. We have previously demonstrated that at this stage of
the immune response ^-80% ofthe antigen-binding cellswere
proplasmacytes and plasmacytes and only these cells inter-
nalized large amounts of HRP (20). All the results reported
below were obtained using macrophage-depleted cell popula-
tions.
Fig. 3 illustrates the antigen-binding capacity of popliteal
lymph node cells incubated 1 h at 4°C with various concen-
Û
ó
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FIGURE 3
￿
Binding of HRP on anti-HRP plasma cells. Macrophage-
depleted popliteal lymph node cells (5 x 10'/ml) were incubated 1
h at 4°C with various concentrations of HRP in modified Click's
medium. Titration of cell-associated HRP was performed with OPD
chromogenic substrate either on living cells (*) or after lysis of cells
with NP-40 (W). As a control, popliteal lymph node cells from rabbit
,y-globulin-immunized rats were prepared as above and incubated
with 100 Ag/ml HRP. No binding of HRP could be detected on
these cells (p).
Total amount of cell-as-
sociated HRP at 37°C
Total amount of cell-as-
sociated HRP at 4°C
1 .042 ± 0.165
Normal lymphoid cells were incubated 1 h at 4°C or 37°C with a saturating concentration (100 to 400 vg/ml) of HRP-labeled sheep anti-rat Ig (Fab')2
conjugate. Then, HRP activity was titrated on living cells (third column) or on cell lysates (fifth column). Differences between the two sets of values are
indicated in the fourth column. The ratios of the total amounts of cell-associated HRP titrated at 37°C and 4°C are present in sixth column. Nonspecific
binding and internalization were estimated by incubating aliquots of the same cell suspensions with HRP-labeled normal sheep (Fab')2 fragments not filtered
or filtered on Sephacryl S-200. Values obtained with these conjugates did not represent >5-10% of the values obtained with the specific conjugates.
* Means t one standard deviation of five experiments. The conjugate used in these experiments was not filtered on Sephacryl S-200 column. With the
glutaraldehyde coupling procedure, -20% of the (Fab'), fragments are usually linked to HRP (8). So the presence in this conjugate of high amounts of
unlabeled (Fab')2 fragments competing with the labeled molecules explains the lower quantities of cell-associated HRP compared to values obtained with
the filtered conjugate.
= Means of two experiments. In these experiments, we have selected HRP-(Fab')2 conjugate free of unlabeled molecules. Its HRP/(Fab')2 molar ratio was 1 .8-
1 .9.
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Binding
TABLE II
and Internalization of HRP-labeled Sheep Anti-rat Ig (Fab')2 by B Lymphocytes
Tempera-
ture ofin-
cubation Amount of HRP Amount of NP-40 Total amount of
with conju- detected on 10' releasable HRP/ cell-associated HRP
Conjugate gate living cells 10' cells (ng)/10' cells
.C ng ng
Not filtered 4 8.4 ± 1 .2` 3.3 ± 1 .1 11 .7 ± 2.0
37 2.6 ± 0.1 9.6 ± 1 .7 12 .2 ± 1 .8
Sephacryl S-200 filtered 4 64.9= 11 .5 76.5
37 13.9 83 96.9trations of HRP. As both the percentage of ligand-binding
cells and the number of surface receptors were lower than in
the experiments on B lymphocytes, the more sensitive OPD
substrate was used to measure the cell-associated HRP activ-
ity. A plateau was reached at 50,ag/ml HRP, but if saturation
of the binding sites was always obtained with this concentra-
tion,the maximum amount ofHRP bound to 10' cells ranged
between 0.3 and 1 .8 ng/10' cells. This was due to differences
in the percentage of HRP-binding cells present in popliteal
lymph nodes (Fig. 4A). Binding of HRP on anti-HRP plasma
cells occurred through specific receptors since no binding
could be detected on anti-rabbit -y-globulin lymphoid cells
incubated 1 h at 4°C with 100 ,Lg/ml HRP (Fig. 3). It is also
obvious from Fig. 3 that no endocytosis ofantigen took place
at this temperature as no HRP activity was released by treat-
ment of cells with NP-40. Pronase treatment of cells previ-
ously incubated 1 h at 4°C with HRP confirmed this point.
Indeed, in these conditions, the proteolytic enzyme removed
95 to 100% of the cell-associated HRP activity (Fig. 5).
Internalization of HRP by Anti-HRP Plasma Cells
In a previous paper(21), we demonstrated that HRP uptake
in plasma cells was a saturable process over 50 ug HRP/ml
of culture medium. In the present experiments, HRP uptake
was studied as a function of time. Fig. 5 shows a typical
experiment in which one portion of cells was incubated for 1
h at 4°C with 100 Ag/ml HRP to estimate their binding
capacity and the other portion for 1, 3, and 6 h at 37°C with
the same dose of antigen. Uptake of HRP, measured after
lysis of cells with NP-40, increased linearly with time at 37°C
and exceeded by several times the binding at 4°C. This in-
crease was not explained by the fluid-phase endocytosis of
HRP. Indeed, at the same concentration of HRP, anti-rabbit
ó 2
C
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~ 2.5
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HRP-BINDING CELLS (*/.)
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HRP- INTERNALIZING CELLS
FIGURE 4
￿
Correlation between the amount of cell-bound HRPand
the percentage of HRP-binding cells (A) or HRP-internalizing cells
(B). (A) Abcissa: nanograms of HRP bound by 10' cells incubated 1
h at 4°C with 100 leg/ml HRP. Ordinate: percentage of HRP-binding
cells in the same cell suspensions calculated after counting 1,000-
1,500 total lymph node cells. (B) Abcissa: uptake of HRP by 10'
cells incubated 3 h at 37°C with 100 FAg/ml HRP. Ordinate: per-
centage of HRP-internalizing cells in the same cell suspensions.
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FIGURE 5
￿
Uptake of HRP by anti-HRP plasma cells. Macrophage-
depleted popliteal lymph node cells were incubated at 4°C (time
0) or 37°C with 100 vg/ml HRP in modified Click's medium. After
1 h at 4°C and 1, 3, and 6 h at 37°C, aliquots of cells were
withdrawn and cell-associated activity estimated by using OPD as
chromogenic substrate. (0) Nanograms of HRP/10' cells removed
by pronase (plasma membrane bound-HRP); (()) nanograms of
internalized HRP/10' cells; (F-1W total amount of cell-associated
HRP in ng/10' cells. Uptake of HRP by fluid phase endocytosis was
measured by incubating anti-rabbit -y-globulin lymphoid cells as
above with 100 ug/ml HRP and total cell associated activity titrated
with OPD substrate (a-----6).
-y-globulin lymphoid cells internalized 5 to 10 times smaller
amounts of HRP than specific plasma cells (Fig. 5). The
amount ofcell-surface bound HRP was estimated after treat-
ment of living cells with pronase. As shown in Fig. 5, the
number of HRP molecules removed by pronase on living
cellswas constant for 6 h at 37°C and remained equal to that
found at 4°C. This indicates that, on the contrary to what
happened in B lymphocytes (Fig. 2), the surface binding
capacity of plasma cells was unchanged even after 6 h of
incubation at 37°C with HRP. The amount ofHRP associated
to a given number ofcellsdepended on the percentage ofcells
in which HRP was detected cytochemically (HRP-intemaliz-
ing cells) (Fig. 4B). HRP-binding cellsand HRP-internalizing
cellswere very likely the same cells because their number was
roughly the same (Fig. 6), and they belonged to the same cell
types (20, 21). Furthermore in most HRP-labeled cells both
plasma membrane and intracytoplasmic staining could be
detected. An average value of 37°C uptake/4°C binding ratio
was calculated from data offive separate experiments. It was
found to be of 6.5 and 11 .5 after 3 and 6 h of incubation at
37°C, respectively. No adjustment for degradation of HRP
was needed in our calculations, since no significant decrease
in HRP activity was noticeable before 6 h after initial pene-
tration (21 ).
Taken together, these data then demonstrate an ability of
plasma cells to endocytoseHRP far exceeding the number of
available surface-binding sites. However, it was possible that
values obtained at 4°C underestimated the real binding capac-
ity. To test this hypothesis, we incubated cellsfor 1 h at 37°C
with various concentrations ofHRP in the presence ofsodium
azide (10-2 M), which is a good inhibitor of the endocytic
process of antigen by plasma cells (19). Under these condi-TIME AT 37'C (h)
FIGURE 6
￿
Uptake of HRP by anti-HRP plasma cells in presence or
absence of cycloheximide. Macrophage-depleted popliteal lymph
node cells were preincubated for 1 h at 37°C with or without 20
vg/ml cycloheximide before adding 100 /,Lg/ml HRP. After 1 h at
4°C and 3 or 6 h at 37°C, samples of cells were washed and total
amount of cell-associated HRP determined on cell lysates with
OPD substrate. (F-i) total amount of cell-associated HRP in ng/
107 cells not treated with cycloheximide; (t----i) total amount of
cell-associated HRP in ng/107 cycloheximide-treated cells. In par-
allel, aliquots of cells were prepared for cytochemical detection of
HRP-labeled cells. After cytocentrifugation and fixation of cells,
HRP was revealed using 3-amino-9-ethyl carbazole substrate. Re-
sults are expressed in percent of lymphoid cells labeled with HRP.
(p-
￿
o) percent of HRP-labeled cells in control group not treated
with cycloheximide; (p-----p) percent of HRP-labeled cells in cyclo-
heximide-treated group.
tions, no change in the amount ofcell-bound HRP was found
compared to 4°C, suggesting no effect of temperature on the
affinity or amount ofbinding (data not shown).
Effect of Cycloheximide on HRP Binding and
Uptake in Plasma Cells
The effect of cycloheximide was tested to determine
whether continuous uptake of HRP depended on de novo
synthesis of new receptors during the 6 h of incubation at
37°C. The rate of HRP receptor turnover was first investi-
gated. Cells were maintained at 37°C in the presence of
cycloheximide. At various times, aliquots ofcells were cooled
and assayed for HRP binding. No decrease in number of
surface receptors was observed up to 6 h. After 6 h, an increase
of cellular mortality was noted. The following experiments
were then designed to directly assess the effect of cyclohexi-
mide on HRP uptake. Cells were preincubated for 1 h at 37°C
with or without (control cells) 20 ug/ml cycloheximide. A
portion of cells was then cooled to 4°C to determine the
number of binding sites. The other portion was incubated at
37°C up to 6 h with 100 fug/ml HRP in the presence or
absence of cycloheximide. After 3 and 6 h, uptake was deter-
mined in control and cycloheximide-treated cells. Fig. 6
clearly indicates the absence of effect of cycloheximide on
HRP uptake.
In addition, it might be argued that the presence of soluble
anti-HRP antibody secreted by plasma cells in the culture
medium could affect antigen internalization. This can be
ruled out from the results presented in Fig. 7. Cells from anti-
HRP rats were preincubated for 1 to 6 h at 37°C with 20,ug/
ml cycloheximide and then tested for the presence of anti-
HRP antibody-secreting cells by a local haemolysis plaque
assay. After 1 h of preincubation with the drug the secretion
of antibody was already drastically reduced and after2 h only
few cellsstill secreted detectable amount ofantibody. In these
conditions uptake ofHRP was found to be normal (Fig. 6).
HRP Binding and Uptake in Pronase-treated
Plasma Cells
Continuous HRP uptake could be due to a large intracel-
lular pool of receptors replacing those which mediated endo-
cytosis of HRP. To test this hypothesis, we treated cells with
pronase to eliminate receptors for HRP. These experiments
were performed at 4°C to avoid a possible proteolysis of
cycling receptors. In the experiment shown in Fig. 8A, cells
were incubated for 15 min at 4°C with pronase. About 85-
95% of the binding activity was lost after treatment with
pronase. Cells were then incubated at 37°C with 100 ug/ml
HRP with or without cycloheximide. After 3 h, HRP uptake
was found to be about 20% of control values. Between 3 and
6 h, we observed a rapid recovery of uptake capacity. How-
ever, such a recovery could be prevented by cycloheximide,
suggesting that uptake was mediated by new receptors emerg-
ing on the cell surface between 3 and 6 h ofincubation. The
following experiments support this hypothesis. Pronase-
treated cells were incubated at 37°C in the absence of HRP
and assayed at varying times for HRP binding. As shown in
Fig. 8B, only 10 to 20% of binding sites reappearedafter 3 h
of incubation. At 6 h, cells had recovered fully their binding
capacity and even more, but this recovery was not observed
in the presence of cycloheximide. In control experiments it
was verified that pronase treatment of lymphoid cells did not
alter the fluid-phase endocytosis of HRP (data not shown).
"
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FIGURE 7 Inhibition of Ig secretion by cycloheximide. Popliteal
lymph node cells from anti-HRP rats were incubated at 37°C for
various periods of time with (9-----e) or without (~---~) 20 ug/ml
cycloheximide. After 0, 1, 2, 3, 4, 5, and 6 h, aliquots of cells were
withdrawn and the number of anti-HRP antibody-secreting cells
determined by a haemolytic plaque assay. Results are expressed as
percent of the number of antibody-secreting cells found before
incubation at 37°C (36,500/106 lymphoid cells). Each point is the
mean of triplicate determinations.
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FIGURE 8
￿
Binding and uptake of HRP by pronase-treated anti-HRP
plasma cells. Macrophage-depleted popliteal lymph node cells
were incubated for 15 min at 4°C in modified Click's medium
without fetal calf serum containing 2 mg/ml pronase and 50 Ag/ml
DNAse II (0). Control cells (O) were maintained in the same medium
without enzyme. The treatment with pronase led to approximately
90% decrease in HRP binding. (A) Cells were incubated at 37°C
with 100 jig/ml HRP. Pronase-treated cells were cultured with
(-----) or without (-) 20 jug/ml cycloheximide. After 3 and 6 h,
aliquots of cells of each group were lysed with NP-40 to deter-
mine HRP uptake. (8) Cells were incubated at 37°C without
HRP. Pronase-treated cells were cultured with (-----) or without
(-) 20 Ag/ml cycloheximide. After 3 and 6 h, aliquots of cells
were assayed for HRP binding. The data are presented in terms of
the percentage of HRP binding on pronase-treated cells to control
cells.
This indicates that inhibition of HRP uptake induced by
pronase digestion of anti-HRP-specific cells was not due to a
general decrease of plasma membrane activity.
The carboxylic ionophore monensin has been shown to
interrupt the recycling of low density lipoprotein receptors in
human fibroblasts (7). In our study the effect of this drug on
the number of surface Ig and of antigen-binding sites ex-
pressed on B lymphocytes and plasma cells, respectively, has
been tested. Cells were maintained for various times at 37°C
in the presence of monensin and then assayed for HRP-anti-
rat Ig Fab' conjugate or HRP binding. As shown in Fig. 9, no
effect of monensin was found on B lymphocyte-binding
activity. On the contrary, monensin induced a progressive
loss of HRP-binding sites from plasma cell surface (Fig. 9). In
addition, HRP uptake was inhibited by 50% after 3 h of
incubation at 37°C in the presence of 10'6 M monensin.
However, the inhibition of HRP uptake was not due to the
blockade of the first step of endocytosis of HRP as shown by
the following experiment. After a short preincubation for 15
min at 37°C with or without monensin, cells were incubated
at 4°C with HRP, washed and transferred at 37°C for 30 min
and 1 h to allow internalization of previously bound HRP.
The amount ofNP-40 releasable HRP increased at the same
1244
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rate whether monensin was present or not in the medium
(Table III).
DISCUSSION
The aim of this study was to determine whether cell differ-
entiation state can affect receptor behavior during the recep-
tor-mediated endocytosis process. B lymphocytes and plasma
cells represent a convenient system to address this question.
Indeed, B cell differentiation results in the development of
endoplasmic reticulum and enlargement of the Golgi appa-
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FIGURE 9
￿
Effect of monensin on the number of surface Ig of B
lymphocytes and on the number of anti-HRP surface receptors of
plasma cells. Macrophage-depleted lymph node cells from nonim-
munized and anti-HRP rats were maintained at 37°C without mo-
nensin (control cells) or with 10-6 M (0, cells from nonimmunized
rats; (") cells from anti-HRP rats) or 10-s M (E, cells from nonim-
munized rats) monensin. After various times at 37°C, aliquots of
cells were washed and incubated 1 h at 4°C with HRP-labeled anti-
rat Ig Fab' fragments (B lymphocytes) or HRP (plasma cells). After
further washings, HRP binding was then determined. The data are
presented in terms of the percentage of binding on monensin-
treated cells to control cells. Results are the means of two separate
experiments.
TABLE III
Effect of Monensin on the First Step of HRP Internalization
Amount of HRP
detected on 107 ￿Amount of NP-40 releasable HRP/
living cells
￿
107 cells transferred at 37°C
incubated at
Monensin
￿
4°C
￿
0 min
￿
30 min
￿
1 h
- 0.82 0 0.28 0.55
+ 0.80 0 0.21 0.55
Cells were preincubated with or without 10-` M monensin for 15 min at
37°C. They were then incubated for 1 h at 4°C with 100 ug/ml HRP in the
presence or absence of monensin. After three washings, a portion of cells
was assayed for HRP binding. The other portion was transferred at 37°C in
HRP-free medium with or without 10-6 M monensin. After 30 min and 1 h,
HRP activity was measured before and after lysis of cells with NP-40. The
differences between these two values give the amount of HRP liberated with
NP-40. Lysis of cells incubated for 1 h at 4°C with HRP did not increase the
amount of titrable cell-bound HRP (time 0 min) which indicates that no
internalization occurs at this temperature.ratus, allowing biosynthesis and secretion of antibody at a
high rate. We took advantage in this study of the fact that
both B lymphocytes and plasma cells express surface Ig that
mediate endocytosis ofantigen or anti-Ig antibodies.
Because the frequency of antigen-specific B lymphocytes in
normal and immunized animals is extremely low, we used
anti-rat Ig Fab' fragment as a model ligand, because of its
capacity to react with all B lymphocytes. The binding ofHRP-
anti-Ig Fab' conjugate was followed by its progressive inter-
nalization and simultaneously the plasma membrane became
progressively unable to bind the conjugate. Between 1 and 6
h of incubation at 37°C in the presence of conjugate, the total
amount of cell-associated HRP remained constant. That in-
dicates that during this time, no reappearance of free surface
Ig occurred by neosynthesis, recycling, or the expression of
an intracellular pool. However, after 1 h at 37°C in presence
of conjugate, cell-associated HRP activity was twice greater
than that titrated on cells incubated for 1 h at 4°C with the
same saturating dose of conjugate. Experiments performed
with cycloheximide or on cells treated with pronase allowed
to exclude a rapid neosynthesis or the expression of an intra-
cellular pool of surface Ig to explain this increase. Evidence
for the absence of a large intracellular pool of membrane Ig
in B lymphocytes has been already obtained by Andersson et
al. (1). Table II shows that rise in cell-associated HRP activity
between 1 h at 4°C and 1 h at 37°C was absent or much less
pronounced when we used HRP-labeled anti-rat Ig (Fab')z
bivalent conjugate instead of the monovalent conjugate. One
explanation could be that a cross-linking ligand induces at
4°C membrane modifications leading to the recruitment of
new receptors or antigenic determinants otherwise inaccessi-
ble. Similar data have been obtained by Bornens et al. (9).
Indeed, these authors have found that rat thymocytes were
able to bind twice as many molecules of concanavalin A as
ofsuccinyl-concanavalin A which, unlike the native molecule
does not have the capacity to induce patches and caps on
lymphocytes.
Recycling of small and progressively decreasing amount of
surface Ig always complexed with the ligand cannot be totally
discarded by our experiments. However, the main effect of
the internalization of monomeric ligand-surface Ig complexes
in B lymphocytes is a temporary down-regulation of surface
Ig, which leads to a rapid shut off of the ligand uptake. These
results confirm those previously obtained with multivalent
ligands (antigen or anti-Ig antibodies) that induced redistri-
bution of surface Ig on the plasma membrane before inter-
nalization (27, 35). In B lymphocytes, regeneration ofsurface
Ig appears then to require de novo synthesis (45).
Plasma cells exhibit striking differences in the uptake of
monomeric ligand. The first difference concerns the constant
binding capacity of plasma cells with time of incubation at
37°C with HRP. The second difference concerns the contin-
uous uptake of antigen with time of incubation at 37°C, that
exceeds surface binding capacity ofcells.
Antigen uptake proceeds continuously for at least 24 h
(unpublished results). This indicates that, after one round of
receptor-mediated endocytosis, anti-HRP receptors were
again present on the cell surface to mediate new cycles of
internalization.
The experiments with cycloheximide show that, in the
absence of ligand, the rate of receptor turnover was slow and
that the maintenance of binding activity was not due to de
novo synthesisofreceptors. Also, HRP uptake was not affected
by blockade of protein synthesis. These data clearly demon-
strates that receptors replacing at the cell surface those inter-
nalized with HRP were not resynthesized by plasma cells. In
addition, in the presence ofcycloheximide, antibody secretion
was drastically reduced. Some effect on antigen internaliza-
tion of soluble antibody present in the culture medium can
then be ruled out.
Alternatively, continuous HRP uptake could be due to a
progressive externalization of a large pool of pre-synthesized
receptors inside the cells. However, after removal of surface-
binding sites with pronase and in the absence of protein
synthesis, plasma cells recovered after 6 h at 37°C only 10 to
20% oftheir binding activity. It should be notedthat pronase-
treated plasma cells were able to resynthesize new receptors
faster than expected from the rate of receptor turnover found
in untreated cells (no decrease in binding activity during 6 h
of incubation with cycloheximide). Such a phenomenon has
been already described for other receptors after treatment
with a proteolytic enzyme (10). HRP uptake was also consid-
erably lowered in pronase-treated cells and the remaining
uptake could be attributed for the most part to fluid-phase
endocytosis. These data then indicate that intracellular pool,
if exists, was very small in comparison of the surface pool.
Therefore, the best explanation for continuous HRP uptake
is that antigen surface receptors that enter the cellsare disso-
ciated from their ligand and are reexported to the cell surface
to be reused.
As shown in Fig. 9, monensin caused a progressive loss of
receptors from the cell surface of plasma cells, but not of B
lymphocytes. Given that the first step ofthe endocytic process
was not affected, this could explain the inhibition of contin-
uous HRP uptake we observed in monensin-treated cells.
These data suggest that a constitutive endocytosis ofreceptors
(or of a part of receptors) takes place in plasma cells. In
secretory cells, monensin probably disrupts an ion gradient
that is crucial for budding of vesicles from the Golgi complex,
which leads to a blockade of secretion (38, 39, 44). In plasma
cells this drug causes the immunoglobulins to accumulate
within the Golgi complex, whose cisternae become dilated
(38). In our experiments, a 10-6 M concentration of monensin
diminishedthe number of anti-HRP antibody-secreting cells,
detected by a local haemolysis plaque assay, by 80% in 2 h.
These data raise then the possibility of a coupling between
endocytosis and exocytosis in plasma cells. Such a coupling
is thought to be necessary for the remodeling of cell surface
after exocytosis in other secretory cells (15, 24, 33). In addi-
tion, secreted Ig is not concentrated in plasma cells, but is
very likely released by continual exocytosis (38), which sug-
gests that an extensive membrane traffic probably occurs in
plasma cells (32, 40). However, given that monensin may act
at several points along the endocytic pathway (14, 28, 34),
further investigation is needed to firmly establish that mem-
brane recycling takes place in plasma cells.
As mentioned in the introduction, evidence existsthat some
features of the receptor may determine whether it is degraded
along with the ligand or recycled back to the plasmalemma.
Membrane Ig ofB lymphocytes seems to behave like receptor
ofhormones or neurotransmitters that are not recycled in the
presence of the ligand (17) or recycled at a very slow rate (16).
However plasma cellsseems to differ in the cycling of surface
Ig from their progenitors, B lymphocytes. As far as studied,
ligands (antigen, monovalent, or divalent anti-Ig antibodies)
are delivered to the same intracellular sites in B lymphocytes
GOUD AND ANTOINE Surface Ig Recycling and B Lymphocyte Differentiation
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1245and plasma cells (3, 20, 21). One possibility to explain surface
Ig recycling in plasma cells could be that a new membrane
traffic or the amplification of a membrane traffic already
existing in B lymphocytes is established in plasma cells be-
tween sites of receptor-mediated endocytosis and plasma-
lemma. This emphasizes that cell differentiation state can
affect endocytic receptor recycling.
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